Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson's disease

Metabolic Brain Disease

Volumn 25, Issue 2, 2010, Pages 177-183

  Kuroiwa, Hayato ^a   Yokoyama, Hironori ^a   Kimoto, Hiroki ^a   Kato, Hiroyuki ^b   Araki, Tsutomu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Dopaminergic system; Mice; MPTP; Striatum; Western blot

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMOVANILLIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; MALE; MOUSE; NERVE CELL LESION; NONHUMAN; PARKINSON DISEASE; WESTERN BLOTTING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BIOLOGICAL MARKERS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HOMOVANILLIC ACID; MALE; MICE; MICE, INBRED C57BL; NEUROTOXINS; PARKINSONIAN DISORDERS; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 77954085675     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-010-9195-9     Document Type: Article

References (21)

1. Y Agid 1991 Parkinson's disease: pathophysiology Lancet 337 1321 1324 10.1016/0140-6736(91)92989-F 1:STN:280:DyaK3M3jt1aqug%3D%3D 1674304
2. T Araki T Kumagai K Tanaka M Matsubara H Kato Y Itoyama Y Imai 2001 Neuroprotective effect of riluzole in MPTP-treated mice Brain Res 918 176 181 10.1016/S0006-8993(01)02944-4 1:CAS:528:DC%2BD3MXnvFCksLw%3D 11684056 (Pubitemid 33001503)
3. T Araki T Mikami H Tanji M Matsubara Y Imai M Mizugaki Y Itoyama 2001 Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-2, 3, 6-tetrahydropyridine (MPTP)-treated mouse Eur J Pharm Sci 12 231 238 10.1016/S0928-0987(00)00170-6 1:CAS:528:DC%2BD3cXoslGhtLk%3D 11113642
4. H Bernheimer W Birkmayer O Hornykiewicz K Jellinger F Seitelberger 1973 Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J Neurol Sci 20 415 455 10.1016/0022-510X(73)90175-5 1:CAS:528:DyaE28XlvFSgt7k%3D 4272516
5. M Gerlach P Riederer 1996 Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man J Neural Transm 103 987 1041 10.1007/BF01291788 1:CAS:528:DyaK28XntVKku7Y%3D 9013391 (Pubitemid 26383833)
6. H Hallman J Lange L Olson I Stromberg G Jonsson 1985 Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine on brain catecholamine neurons in the mouse J Neurochem 44 117 127 10.1111/j.1471-4159.1985.tb07120.x 1:CAS:528:DyaL2MXntlKqsA%3D%3D 3880581 (Pubitemid 15190742)
7. RE Heikkila A Hess RC Duvoisin 1984 Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyidine in mice Science 224 1451 1453 10.1126/science.6610213 1:CAS:528:DyaL2cXkvVertr0%3D 6610213
8. RE Heikkila BA Sieber L Manzino PK Sonsalla 1989 Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse Mol Chem Neuropathol 10 171 183 10.1007/BF03159727 1:CAS:528:DyaK3cXntFKrtA%3D%3D 2669769
9. MW Jakowec GM Petzinger 2004 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates Comp Med 54 497 513 1:CAS:528:DC%2BD2cXhtVejsrrE 15575363
10. R Kurosaki Y Muramatsu H Kato Y Watanabe Y Imai Y Itoyama T Araki 2005 Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice Eur Neuropsychopharmacol 15 57 67 10.1016/j.euroneuro.2004. 05.007 1:CAS:528:DC%2BD2cXhtVantb7L 15572274 (Pubitemid 39574400)
11. JW Langston P Ballard JW Tetrud I Irwin 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980 10.1126/science.6823561 1:STN:280:DyaL3s7hvF2mtg%3D%3D 6823561
12. JW Langston EB Langston I Irwin 1984 MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects Acta Neurol Scand Suppl 100 49 54 1:CAS:528:DyaL2cXmt1Cjtrs%3D 6333134
13. PL McGeer S Itagaki H Akiyama EG McGeer 1988 Rate of cell death in parkinsonism indicates active neuropathological process Ann Neurol 24 574 576 10.1002/ana.410240415 1:STN:280:DyaL1M7pt1Wqtg%3D%3D 3239957
14. CW Olanow AH Schapira Y Agid 2003 Neuroprotection for Parkinson's disease: prospects and promises Ann Neurol 53 Suppl. 3 S1 S2 10.1002/ana.10566 12666093 (Pubitemid 36368557)
15. M Ookubo H Yokoyama S Takagi H Kato T Araki 2008 Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice Mol Cell Endocrinol 296 87 93 10.1016/j.mce.2008.07.019 1:CAS:528:DC%2BD1cXhsVWmsbvJ 18755240
16. GA Ricaurte JW Langston LE Delanney I Irwin SJ Peroutka LS Forno 1986 Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: a neurochemical and morphological reassessment Brain Res 376 117 124 10.1016/0006-8993(86)90905-4 1:CAS:528:DyaL28XksVSntb4%3D 3487376 (Pubitemid 16046022)
17. RJ Smeyne V Jackson-Lewis 2005 The MPTP model of Parkinson's disease Brain Res Mol Brain Res 134 57 66 10.1016/j.molbrainres.2004.09.017 1:CAS:528:DC%2BD2MXisFGmu70%3D 15790530 (Pubitemid 40409495)
18. PK Sonsalla RE Heikkila 1986 The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice Eur J Pharmacol 129 339 345 10.1016/0014-2999(86)90444-9 1:CAS:528:DyaL2sXhsVejug%3D%3D 3490988
19. S Takagi N Hayakawa H Kimoto H Kato T Araki 2007 Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice J Neural Transm 114 1553 1557 10.1007/s00702-007-0790-9 1:CAS:528:DC%2BD2sXhtlOru77I 17676428 (Pubitemid 350212013)
20. Y Watanabe H Kato T Araki 2008 Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease Metab Brain Dis 23 51 69 10.1007/s11011-007-9080-3 1:CAS:528:DC%2BD1cXhslOlu7s%3D 18030609
21. H Yokoyama S Takagi Y Watanabe H Kato T Araki 2008 Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice J Neural Transm 115 831 842 10.1007/s00702-008-0019-6 1:CAS:528:DC%2BD1cXmslWrs7k%3D 18235988